DEPAKOTE Drug Patent Profile
✉ Email this page to a colleague
When do Depakote patents expire, and what generic alternatives are available?
Depakote is a drug marketed by Abbvie and Abbott and is included in four NDAs.
The generic ingredient in DEPAKOTE is divalproex sodium. There are eighteen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the divalproex sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Depakote
A generic version of DEPAKOTE was approved as divalproex sodium by APOTEX on July 29th, 2008.
Summary for DEPAKOTE
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 4 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 67 |
Clinical Trials: | 97 |
Patent Applications: | 4,850 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for DEPAKOTE |
Drug Sales Revenues: | Drug sales revenues for DEPAKOTE |
What excipients (inactive ingredients) are in DEPAKOTE? | DEPAKOTE excipients list |
DailyMed Link: | DEPAKOTE at DailyMed |
Recent Clinical Trials for DEPAKOTE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Virginia Commonwealth University | Phase 1/Phase 2 |
Puma Biotechnology, Inc. | Phase 1/Phase 2 |
Barretos Cancer Hospital | Early Phase 1 |
Pharmacology for DEPAKOTE
Drug Class | Anti-epileptic Agent Mood Stabilizer |
Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
US Patents and Regulatory Information for DEPAKOTE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie | DEPAKOTE | divalproex sodium | CAPSULE, DELAYED REL PELLETS;ORAL | 019680-001 | Sep 12, 1989 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Abbvie | DEPAKOTE ER | divalproex sodium | TABLET, EXTENDED RELEASE;ORAL | 021168-002 | May 31, 2002 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Abbvie | DEPAKOTE | divalproex sodium | TABLET, DELAYED RELEASE;ORAL | 018723-002 | Mar 10, 1983 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Abbvie | DEPAKOTE ER | divalproex sodium | TABLET, EXTENDED RELEASE;ORAL | 021168-001 | Aug 4, 2000 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for DEPAKOTE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie | DEPAKOTE | divalproex sodium | TABLET, DELAYED RELEASE;ORAL | 018723-002 | Mar 10, 1983 | ⤷ Try a Trial | ⤷ Try a Trial |
Abbvie | DEPAKOTE | divalproex sodium | TABLET, DELAYED RELEASE;ORAL | 018723-003 | Oct 26, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
Abbvie | DEPAKOTE | divalproex sodium | TABLET, DELAYED RELEASE;ORAL | 018723-003 | Oct 26, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
Abbvie | DEPAKOTE | divalproex sodium | CAPSULE, DELAYED REL PELLETS;ORAL | 019680-001 | Sep 12, 1989 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for DEPAKOTE
See the table below for patents covering DEPAKOTE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
World Intellectual Property Organization (WIPO) | 8100562 | ⤷ Try a Trial | |
Germany | 3063328 | ⤷ Try a Trial | |
Canada | 1136151 | SEL MIXTE D'ACIDE VALPROIQUE (MIXED SALT OF VALPROIC ACID) | ⤷ Try a Trial |
Italy | 8024207 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |